glp-1 regain weight based drugs: Could Elon Musk's loss weapon help us, too? GLP-1 can be a powerful

In 2021, the oral formulation of semaglutide became available, and this new dosing option resulted in much greater uptake

Doria A, Galecki AT, Spino C et al (2020) Serum urate lowering with allopurinol and kidney function in type 1 diabetes

Mounjaro, scientifically known as tirzepatide, is a prescription medication primarily manufactured by Eli Lilly, specifically designed to manage type 2 diabetes in adults

Neurosci Res 55:352360 Jang H, Kim S, Kim H, Oh SH, Kwak SY, Joo HW, Lee SB, Jang WI, Park S, Shim S (2022) Metformin protects the intestinal barrier by activating goblet cell maturation and epithelial proliferation in radiation-induced enteropathy

The Danish firm is working toward its own oral version of Ozempic and is seeking approvals for pediatric use, which would significantly boost its addressable market

By 2026, it is widely regarded as the benchmark GLP-1 compound against which newer weight loss therapies are measured